Susquehanna International Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,395
Closed -$40.1K 13570
2023
Q1
$40.1K Buy
5,395
+3,383
+168% +$28.4K ﹤0.01% 11789
2022
Q4
$14.6K Buy
+2,012
New +$16.9K ﹤0.01% 11854
2022
Q3
Sell
-4,022
Closed -$77K 14466
2022
Q2
$77K Buy
4,022
+1,438
+56% +$37.2K ﹤0.01% 11702
2022
Q1
$128K Buy
2,584
+1,105
+75% +$57.3K ﹤0.01% 11725
2021
Q4
$112K Buy
1,479
+436
+42% +$29.8K ﹤0.01% 12064
2021
Q3
$82K Sell
1,043
-3,662
-78% -$368K ﹤0.01% 12167
2021
Q2
$653K Sell
4,705
-4,381
-48% -$836K ﹤0.01% 8914
2021
Q1
$1.9M Buy
9,086
+6,635
+271% +$1.33M ﹤0.01% 6048
2020
Q4
$407K Buy
2,451
+825
+51% +$127K ﹤0.01% 8703
2020
Q3
$276K Buy
+1,626
New +$235K ﹤0.01% 8881

Susquehanna International Group's HARP Position: Q2 2023 in Review

Susquehanna International Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 5,395 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in HARP in Q3 2020 and held it in 10 quarters. The position peaked at $1.9M in Q1 2021. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

  • Susquehanna International Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 5,395 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Susquehanna International Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.